# OnCo record pas-004 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/pas-004/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "pas-004" ;
  schema:name "PAS-004"@en ;
  schema:description "PAS-004 is an experimental small molecule from Pasithea Therapeutics, in phase 1 trials for MAPK pathway-driven advanced solid tumours and NF1-associated plexiform neurofibromas."@en ;
  schema:url <https://onco.cc/drugs/pas-004/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1841330/000121390026036434/ea0275535-10k_pasithea.htm>, <https://www.sec.gov/Archives/edgar/data/1841330/000121390026036434/ea0275535-10k_pasithea.htm>, <https://clinicaltrials.gov/study/NCT06299839>, <https://clinicaltrials.gov/search?intr=PAS-004> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule (oral, macrocyclic)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/mek/> ;
  onco:companies <https://onco.cc/companies/pasithea-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct06299839/>, <https://onco.cc/trials/nct06961565/> .